Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma

NCT00898066 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00898066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
June 30, 2007
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, multiple myeloma and plasma cell neoplasm, precancerous/nonmalignant condition